Anti-oxLDL antibodies - Marker for arterial thromboses in antiphospholipid syndrome?

Clinical Laboratory

Volumn 51, Issue 5-6, 2005, Pages 279-283

  Bećarević, Mirjana ^a   Andrejević, Sladana ^a   Bonači Nikolić, Branka ^a   Obradović, Ivana ^a   Miljić, Predrag ^a   Majkić Singh, Nada ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Anti oxLDL antibodies; Antiphospolipid syndrome; Arterial thromboses; Atherosclerosis; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING TEST; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RECURRENT ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

ANIMALIA;

EID: 21244438346     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gromnica-Ihle E, Schossler W. Antiphospholipid syndrome. Int Arch Immunol 2000 ; 123: 67-76.
2. Sarzi-Puttini P, Atzeni F, Carrabba M. Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome. Minerva Med 2003; 94 (2): 63-70.
3. Brizzi P, Tonolo G, Bertrand G, Carusillo F, Severino C, Maioli M, et al. Autoantibodies against oxidized low density lipoprotein (oxLDL) and LDL oxidation status. Clin Chem Lab Med 2004; 42 (2): 164-70.
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette J, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42 (7): 1309-11.
5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
6. Brandth JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemostasis 1995; 74 (4): 1185-90.
7. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346 (10): 752-63.
8. Koike T. Anticardiolipin antibody, specificity and pathogenesis. Report on the 5th Dresden symposium on autoantibodies, Dresden, October 18-21, 2000.
9. Romero FI, Amengual O, Atsumi T, Khamashta MA, Tinahones FJ, Huges GRV. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Brit J Rheum 1998; 37:883-8.
10. Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis. Am J Clin Pathol 2001; 116 (5): 760-7.
11. George J, Harats D, Gilburd B et al. Immunolocalisation of beta-2glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999; 99: 2227-30.
12. Balasch J, Creus M, Fabregues F. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996; 11: 2310-5.
13. Balasch J, Creus M, Fabregues F. Antiphospholipid antibodies and the outcome of pregnancy after the first in vitro fertilization and embryo transfer cycle. Hum Reprod 1998; 13 (5): 1180-3.
14. Lefvert AK. Heterogeneity of autoantibodies against cardiolipin and oxidatively modified low density lipoproteins revealed by human monoclonal antibodies. (Minisymposium). J Intern Med 2000; 247: 385-90.
15. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systemic review of the literature. Blood 2003; 101: 1827-32.
16. Ames PRJ. Medical Perspective. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus. A unifying "membrane stress syndrome" hypothesis. Lupus 1994; 3: 371-7.
17. Vaarala O. Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases. J Int Med 2000; 247: 381-4.
18. Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 2001; 15: 2073-84.